Combined Oral Contraceptives

Ongoing support for forgoing Rh testing in early pregnancy, medication abortion before six weeks, provider bias on contraceptive counseling adolescents, and local anesthesia before procedural abortion.

Answers for health care providers about birth control options after abortion

OTC birth control pill self-selection, adherence, and interest; IUD expulsion risks; and IUD and implant side effects.

Highlighting one notable research article from each Research Roundup in 2023.

Pain management in abortion care, risk of Rh sensitization with abortion before 12 weeks’ gestation, and contraception information on TikTok.

Patients' preferences for contraceptive educational materials, management of missing IUD strings and migrated IUDs, and providers’ perspectives on how to improve contraceptive counseling.

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.